pyruvaldehyde has been researched along with 7-o-galloyl-d-sedoheptulose in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, KS; Park, CH; Tanaka, T; Yamabe, N; Yokozawa, T | 1 |
1 other study(ies) available for pyruvaldehyde and 7-o-galloyl-d-sedoheptulose
| Article | Year |
|---|---|
7-O-galloyl-D-sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney.
Topics: Aldehydes; Animals; Antioxidants; Blood Glucose; Blotting, Western; Body Weight; Cornus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Glycation End Products, Advanced; Heme Oxygenase-1; Heptoses; Kidney; Kidney Function Tests; Male; Oxidative Stress; Pyruvaldehyde; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2009 |